UNSPSC 51283705: Cefminox

This classification denotes a cephalosporin antibiotic with the molecular formula C16H21N7O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PW08Y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but generally known as cefminox, which bears US NIH Compound Identifier 71141.

UNSPSC 51283705 Cefminox is a Commodity code that does not align with recent state and local procurement activity. The code nominally identifies cefminox, a third-generation cephalosporin antibiotic, yet recent opportunities tagged under this code include naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, fire department medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — none of which are cefminox or pharmaceutical manufacturing supply agreements. The mismatch suggests either a tagging error in the underlying procurement records or that this code has been repurposed in state and local systems for broader pharmaceutical and medical supply procurement without alignment to the UNSPSC taxonomy definition.

Issuing bodies in the recent record span county health departments, state health and human services agencies, municipal fire departments, and multi-state cooperative purchasing alliances, indicating fragmented and diverse demand. Geographically, recent activity appears in Florida (Seminole County), Texas (state HHS), Florida again (City of Tampa), and Minnesota (MMCAP, serving Oregon and other member jurisdictions). The opportunities themselves — ranging from an IFB for naloxone and drug deactivation systems with a due date of July 26, 2023 (a past date suggesting a data error), a Texas HHS RFI for direct-to-manufacturer prescription programs with a response deadline of April 3, 2026, an ITB from Tampa Fire Department for medical and first aid supplies with an estimated contract value of $700,000 and a March 13, 2026 deadline, and an RFP from MMCAP for generic pharmaceuticals and OTC products with a March 26, 2026 deadline — do not support meaningful pursuit under this code. The code shows little relevant recent activity; business development professionals should verify UNSPSC tagging with issuing bodies before investing effort in this category.